flouroquilones C/I in liver diseases is ?
**Core Concept**
Fluoroquinolones are a class of antibiotics that inhibit bacterial DNA gyrase and topoisomerase IV, leading to bacterial cell death. In patients with liver disease, the metabolism of fluoroquinolones is altered, increasing the risk of adverse effects.
**Why the Correct Answer is Right**
The correct answer is related to the fact that fluoroquinolones are primarily metabolized by the liver and excreted in the bile. In patients with liver disease, such as cirrhosis or liver failure, the metabolism of fluoroquinolones is impaired, leading to increased plasma concentrations and a higher risk of adverse effects. This is particularly concerning for drugs like ciprofloxacin and levofloxacin, which have a narrow therapeutic index.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a particular fluoroquinolone or a specific contraindication in liver disease.
**Option B:** This option is incorrect because it is too vague and does not provide a clear reason for contraindication in liver disease.
**Option C:** This option is incorrect because it is a common indication for fluoroquinolones, not a contraindication.
**Clinical Pearl / High-Yield Fact**
In patients with liver disease, it is essential to use caution when prescribing fluoroquinolones and to monitor for signs of toxicity, such as nausea, vomiting, and central nervous system effects. Consider alternative antibiotics, such as beta-lactams or aminoglycosides, which are not primarily metabolized by the liver.
**Correct Answer: C. Nelfinavir.**